NASDAQ
ESSA Pharma Inc. (EPIX) has a free cash flow growth of 38.67% as of Friday, May 29, 2026. This represents a 485.93% increase compared to its 12-month average of -10.02%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.